Herantis Pharma (HRTIS)

Last close As at 17/01/2025

0.00 (0.00%)

Market capitalisation

Herantis Pharma is a Finland-based clinical-stage biotechnology company focussed on developing disease-modifying therapies to stop or reverse the progression of neurodegenerative diseases.

Latest Insights

Healthcare | Non client QV

Herantis Pharma — Potential disease-modifier for PD

Sector

Healthcare

Equity Analyst

Key Management

  • Antti Vuolanto

    Chief Executive Officer

  • Tone Kvåle

    Chief Financial Officer

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free